ConsumerDaily Briefs

Daily Brief Consumer: Amorepacific Group, JD.com Inc (ADR), JD Health, Luckin Coffee, S&P BSE SENSEX Index, Trip.com, Hilton Worldwide Holdings and more

In today’s briefing:

  • Timing Stub Trade on Amorepacific Group with a Key Passive Inflow Event Coming Up
  • [JD.com (JD US, SELL, TP US$30) Target Price Change]: Painful Transition Continues Amid Margin Beat
  • [JD Health (6618 HK) Rating Change]: Strong Profitability Likely Achieved Margin Reversal
  • [Luckin Coffee Inc. (LKNCY US) Company Update]: Is Cotti Coffee Charles Lu’ NeXT Computer?
  • Broad-Based Improvement in India, Add Exposure/Overweight. Buys: Cyclicals in Japan, India, & Taiwan
  • HSTECH Index Rebalance: Float & Capping Changes Lead to US$768m Two-Way Trade
  • Hilton Worldwide Holdings Inc.: A Strong Emergence From The Lull – Key Drivers

Timing Stub Trade on Amorepacific Group with a Key Passive Inflow Event Coming Up

By Sanghyun Park

  • AmoreG has been closely moving relative to Amorepacific Corp (090430 KS) over the past few months, but starting from mid-April, it rapidly entered a downward diversion phase.
  • It appears to have experienced greater sensitivity towards the recent tensions in Sino-Korean relations, possibly due to its higher price correlation with the Chinese market.
  • The issue lies in the timing of entry aimed at reversion, and there may be one upcoming passive inflow event that we should pay attention to in this regard.

[JD.com (JD US, SELL, TP US$30) Target Price Change]: Painful Transition Continues Amid Margin Beat

By Shawn Yang

  • JD reported 1Q23 revenue in-line vs. cons., while non-GAAP net income beat cons and our est. 99% and 74%, respectively.   
  • It’s early to say whether JD is getting out of the puddle, as (1) revenue grew just 1.4% YoY in 1Q23,  (2) the effect of its management change remains uncertain.
  • We maintain SELL, but raise JD’s 2023 non-GAAP net margin from prior 3.2% to 3.34%, and raise TP to US$ 30.  

[JD Health (6618 HK) Rating Change]: Strong Profitability Likely Achieved Margin Reversal

By Shawn Yang

  • JDHealth (JDH) reported C1Q23 top line and non-IFRS operating profit 56% and 78% of our C1H23 estimates. 
  • We now take a more positive view on JDH’s ability to at manage the issue at certain periods and certain areas;
  • We raise TP from HK$44 to HK$57 and rating to BUY. Possible risks include renewed margin pressure from prescription drugs

[Luckin Coffee Inc. (LKNCY US) Company Update]: Is Cotti Coffee Charles Lu’ NeXT Computer?

By Shawn Yang

  • Cotti Coffee has become a head-to-head competitor of Mixue’s Lucky Cup, and to a lesser degree, Luckin. 
  • But what is behind Cotti’s agenda, in our view, is its founder Charles Lu’s aspiration to return to Luckin;
  • The biggest obstacle for Charles to repeat the playbook of Steve Jobs is Chinese security regulator’s refusal, so far, to allow franchised chain to list

Broad-Based Improvement in India, Add Exposure/Overweight. Buys: Cyclicals in Japan, India, & Taiwan

By Joe Jasper

  • Our 2023 outlook remains unchanged as we continue to expect broad-based consolidation with $93 capping upside on MSCI ACWI (ACWI-US), while important downside targets are $86, $84, and $75-77.
  • We still recommend tactical overweight to defensives including gold miners and MSCI ACWI Staples, Health Care, and Utilities, given ACWI-US remains near the top of our expected 2023 trading range.
  • We are now starting to see broad-based improvement, particularly in Japan and India, but also in Taiwan and South Korea. Most of today’s buy recommendations are cyclicals in these countries.

HSTECH Index Rebalance: Float & Capping Changes Lead to US$768m Two-Way Trade

By Brian Freitas


Hilton Worldwide Holdings Inc.: A Strong Emergence From The Lull – Key Drivers

By Baptista Research

  • Hilton Worldwide Holdings delivered an all-around beat in its latest result as travel demand has remained robust, continuing the pattern seen in the back half of last year.
  • This resulted in both the company’s top and bottom line results closing the quarter above the high end of the management guidance.
  • The quarter’s leisure trends continued to be strong, with RevPAR outperforming the previous quarter’s performance.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars